ORAL DOSAGE FORM PRODUCT OF CLOPIDOGREL HYDROGEN SULFATE WITH IMPROVED STABILITY

摘要

The present invention relates to an oral dosage form product containing clopidogrel hydrogen sulfate with improved stability. More specifically, the present invention relates to an oral dosage form product of clopidogrel hydrogen sulfate which is a product in a package form wherein an oral dosage form of clopidogrel hydrogen sulfate is sealed together with an oxygen absorbent, and thus increases the stability to oxidation of clopidogrel hydrogen sulfate so that the generation and increase of related compounds can be suppressed during the storage of the product.